Detailed information for compound 226592

Basic information

Technical information
  • TDR Targets ID: 226592
  • Name: 4-methyl-6-(1-methylbenzimidazol-2-yl)-2-prop yl-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]m ethyl]benzimidazole
  • MW: 538.645 | Formula: C33H30N8
  • H donors: 1 H acceptors: 5 LogP: 6.61 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)cc(cc2C)c1nc2c(n1C)cccc2
  • InChi: 1S/C33H30N8/c1-4-9-30-35-31-21(2)18-24(33-34-27-12-7-8-13-28(27)40(33)3)19-29(31)41(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)32-36-38-39-37-32/h5-8,10-19H,4,9,20H2,1-3H3,(H,36,37,38,39)
  • InChiKey: NOASMCANAQBJTR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole
  • 4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-1-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole
  • 4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-1-[4-[2-(2H-tetrazol-5-yl)phenyl]benzyl]benzimidazole

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Type-1B angiotensin II receptor Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni peptide (FMRFamide/somatostatin)-like receptor Type-1B angiotensin II receptor   359 aa 346 aa 18.2 %
Echinococcus multilocularis G-protein coupled receptor, putative Type-1B angiotensin II receptor   359 aa 307 aa 22.1 %
Schistosoma mansoni peptide (allatostatin)-like receptor Type-1B angiotensin II receptor   359 aa 323 aa 25.7 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 305 aa 24.9 %
Echinococcus multilocularis neuropeptide receptor Type-1B angiotensin II receptor   359 aa 317 aa 24.9 %
Echinococcus granulosus neuropeptide receptor Type-1B angiotensin II receptor   359 aa 317 aa 24.6 %
Loa Loa (eye worm) hypothetical protein Type-1B angiotensin II receptor   359 aa 308 aa 27.6 %
Echinococcus granulosus allatostatin A receptor Type-1B angiotensin II receptor   359 aa 342 aa 27.2 %
Brugia malayi putative neuropeptide receptor NPR1 Type-1B angiotensin II receptor   359 aa 295 aa 27.1 %
Schistosoma mansoni biogenic amine (octopamine/dopamine) receptor Type-1B angiotensin II receptor   359 aa 350 aa 23.1 %
Echinococcus multilocularis thyrotropin releasing hormone receptor Type-1B angiotensin II receptor   359 aa 363 aa 23.4 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 355 aa 23.9 %
Loa Loa (eye worm) hypothetical protein Type-1B angiotensin II receptor   359 aa 329 aa 24.0 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 386 aa 24.4 %
Loa Loa (eye worm) neuropeptide F receptor Type-1B angiotensin II receptor   359 aa 344 aa 23.5 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 292 aa 24.7 %
Echinococcus multilocularis pyroglutamylated rfamide peptide receptor Type-1B angiotensin II receptor   359 aa 365 aa 20.0 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 350 aa 24.0 %
Echinococcus granulosus pyroglutamylated rfamide peptide receptor Type-1B angiotensin II receptor   359 aa 366 aa 19.7 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 309 aa 18.8 %
Schistosoma mansoni opsin-like receptor Type-1B angiotensin II receptor   359 aa 299 aa 25.8 %
Schistosoma japonicum ko:K04209 neuropeptide Y receptor, invertebrate, putative Type-1B angiotensin II receptor   359 aa 307 aa 24.1 %
Echinococcus granulosus growth hormone secretagogue receptor type 1 Type-1B angiotensin II receptor   359 aa 343 aa 23.0 %
Echinococcus granulosus tm gpcr rhodopsin Type-1B angiotensin II receptor   359 aa 300 aa 21.0 %
Brugia malayi GnHR receptor homolog Type-1B angiotensin II receptor   359 aa 357 aa 20.4 %
Echinococcus granulosus thyrotropin releasing hormone receptor Type-1B angiotensin II receptor   359 aa 363 aa 23.7 %
Brugia malayi ORL1-like opioid receptor Type-1B angiotensin II receptor   359 aa 314 aa 20.4 %
Echinococcus multilocularis tm gpcr rhodopsin gpcr rhodopsin superfamily Type-1B angiotensin II receptor   359 aa 300 aa 21.0 %
Echinococcus multilocularis allatostatin A receptor Type-1B angiotensin II receptor   359 aa 342 aa 26.6 %
Onchocerca volvulus E3 ubiquitin-protein ligase rpm-1 homolog Type-1B angiotensin II receptor   359 aa 354 aa 20.6 %
Schistosoma japonicum ko:K04134 cholinergic receptor, invertebrate, putative Type-1B angiotensin II receptor   359 aa 325 aa 20.9 %
Onchocerca volvulus Type-1B angiotensin II receptor   359 aa 314 aa 25.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi AMP deaminase, putative 0.3389 0.6036 1
Loa Loa (eye worm) AMP deaminase 0.3389 0.6036 0.6036
Loa Loa (eye worm) hypothetical protein 0.2688 0.3964 0.3964
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.4732 1 1
Entamoeba histolytica adenosine deaminase, putative 0.4732 1 1
Trypanosoma brucei AMP deaminase, putative 0.3389 0.6036 0.5
Trypanosoma cruzi adenosine monophosphate deaminase-like protein, putative 0.3389 0.6036 1
Onchocerca volvulus AMP deaminase 2 homolog 0.3389 0.6036 0.5005
Trypanosoma cruzi AMP deaminase, putative 0.3389 0.6036 1
Mycobacterium tuberculosis Probable adenosine deaminase Add (adenosine aminohydrolase) 0.4732 1 0.5
Trypanosoma brucei AMP deaminase, putative 0.3389 0.6036 0.5
Leishmania major AMP deaminase, putative 0.3389 0.6036 0.5005
Echinococcus granulosus adenosine deaminase 0.4732 1 1
Loa Loa (eye worm) hypothetical protein 0.2044 0.2063 0.2063
Leishmania major adenine aminohydrolase 0.4732 1 1
Trypanosoma cruzi AMP deaminase, putative 0.3389 0.6036 1
Leishmania major AMP deaminase, putative,amp deaminase-like protein 0.3389 0.6036 0.5005
Leishmania major adenosine monophosphate deaminase, putative,AMP deaminase, putative 0.3389 0.6036 0.5005
Mycobacterium ulcerans adenosine deaminase 0.4732 1 0.5
Trypanosoma brucei adenosine monophosphate deaminase, putative 0.3389 0.6036 0.5
Onchocerca volvulus Adenosine deaminase homolog 0.4732 1 1
Schistosoma mansoni adenosine deaminase-related 0.4732 1 1
Trypanosoma brucei AMP deaminase, putative 0.3389 0.6036 0.5
Loa Loa (eye worm) hypothetical protein 0.2688 0.3964 0.3964
Trichomonas vaginalis adenosine deaminase, putative 0.4732 1 0.5
Schistosoma mansoni adenosine deaminase 0.4732 1 1
Echinococcus multilocularis adenosine deaminase 0.4732 1 1
Trypanosoma cruzi AMP deaminase, putative 0.3389 0.6036 1
Plasmodium vivax adenosine deaminase, putative 0.4732 1 1
Trypanosoma cruzi AMP deaminase, putative 0.3389 0.6036 1
Loa Loa (eye worm) hypothetical protein 0.2688 0.3964 0.3964
Trichomonas vaginalis adenosine deaminase, putative 0.4732 1 0.5
Plasmodium falciparum adenosine deaminase 0.4732 1 1
Toxoplasma gondii Adenosine/AMP deaminase domain-containing protein 0.4732 1 1
Mycobacterium leprae Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) 0.4732 1 0.5
Entamoeba histolytica adenosine deaminase, putative 0.4732 1 1
Loa Loa (eye worm) hypothetical protein 0.4732 1 1
Treponema pallidum adenosine deaminase 0.4732 1 0.5
Leishmania major AMP deaminase, putative,adenosine monophosphate deaminase-like protein 0.3389 0.6036 0.5005
Trypanosoma cruzi adenosine monophosphate deaminase, putative 0.3389 0.6036 1
Loa Loa (eye worm) hypothetical protein 0.2688 0.3964 0.3964

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 13 nM Inhibition of specific binding of [125I]-angiotensin-II to angiotensin 1 receptor in rat lung membrane preparation ChEMBL. 8258826
IC50 (binding) = 13 nM Inhibition of specific binding of [125I]-angiotensin-II to angiotensin 1 receptor in rat lung membrane preparation ChEMBL. 8258826

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.